Diabetes and Coronary Risk Equivalency
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The National Cholesterol Education Program Adult Treatment Panel III (ATP III) listed diabetes as a coronary heart disease (CHD) risk equivalent for setting therapeutic goals for LDL cholesterol (1). A goal for LDL cholesterol of 20%. For the majority of patients with diabetes, this LDL cholesterol goal would evoke the use of cholesterol-lowering drugs, particularly statins. Some investigators have questioned whether most or all patients with diabetes have a CHD risk equivalent and thus require cholesterol-lowering drugs (2). One approach to this issue is to examine epidemiological data relating to absolute risk for developing CHD in various populations of persons with diabetes. In the present issue of Diabetes Care , Howard et al. (3) reported the incidence of CHD in the Strong Heart Study, a cohort study of cardiovascular disease (CVD) in 13 American-Indian tribes/communities conducted in three study centers in southwestern Oklahoma, central Arizona, and North and South Dakota. The population of the Strong Heart Study has a high prevalence of type 2 diabetes and CVD associated with diabetes. The findings of this study showed wide variation in rates of CHD in patients with diabetes, depending in part on coexisting risk factors. Most individuals had 10-year risk >20%, the threshold for ATP III’s CHD risk equivalency, but only those with multiple risk factors had rates of CHD events equivalent to patients with established CHD. The authors conclude that it may be prudent to consider therapeutic goals for risk factors based on the entire risk factor profile, rather than just the presence of diabetes. Other studies likewise have found …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01682-5 · Cited by 691
Self-citationImpact of Diabetes on Mortality After the First Myocardial Infarction
Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & The FINMONICA Myocardial Infarction Register Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.69 · Cited by 665
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Circulation · doi:10.1161/hc3801.097475 · Cited by 661
Self-citationCho, E., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02044-2 · Cited by 225
The Relation of Fasting and 2-h Postchallenge Plasma Glucose Concentrations to Mortality
Sorkin, J. D., Muller, D. C., Fleg, J. L., & Andres, R. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2626 · Cited by 189
Cited by
Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718
Wanner, C., the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members, & Tonelli, M. (2014) · Kidney International · doi:10.1038/ki.2014.31 · Cited by 649
Long-Term Risk of Coronary Events after AKI
Wu, V.-C., Wu, C.-H., Huang, T.-M., Wang, C.-Y., Lai, C.-F., Shiao, C.-C., Chang, C.-H., Lin, S.-L., Chen, Y.-Y., Chen, Y.-M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060610 · Cited by 312
Goff, D. C., Gerstein, H. C., Ginsberg, H. N., Cushman, W. C., Margolis, K. L., Byington, R. P., Buse, J. B., Genuth, S., Probstfield, J. L., & Simons-Morton, D. G. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.002 · Cited by 229
Tonelli, M., Wanner, C., & for the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2453 · Cited by 226
“To maximize the ratio of benefits to harms and costs, future coronary risk is considered an important potential determinant of the decision to prescribe cholesterollowering treatment (2).”
Background
Metadata
- Authors
- Grundy, S. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-02-01
- Volume
- 29
- Issue
- 2
- Pages
- 457-460
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2009047760
- Cited by
- 53
- References
- 9
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes and Coronary Risk Equivalency. https://app.cochat.ai/papers/10.2337/diacare.29.02.06.dc05-1904
- The paper
- Grundy, S. M. (2006). Diabetes and Coronary Risk Equivalency. Diabetes Care. https://doi.org/10.2337/diacare.29.02.06.dc05-1904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.